GLTPD2 anticorps (Alexa Fluor 594)

N° du produit ABIN2813797

Détail du produit anti-GLTPD2 anticorps (Alexa Fluor 594)

Antigène: GLTPD2 (Glycolipid Transfer Protein Domain Containing 2 (GLTPD2))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp GLTPD2 est conjugé à/à la Alexa Fluor 594

Application: Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Réactivité croisée: Humain, Souris, Rat

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human GLTPD2

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur GLTPD2

Antigène: GLTPD2 (Glycolipid Transfer Protein Domain Containing 2 (GLTPD2))

Autre désignation: GLTPD2 (GLTPD2 Produits)

Synonymes: anticorps C730027E14Rik, anticorps RP23-122P1.9, anticorps RGD1560459, anticorps glycolipid transfer protein domain containing 2, anticorps GLTPD2, anticorps Gltpd2

Sujet:

Synonyms: glycolipid transfer protein domain-containing protein 2, Glycolipid transfer protein domain containing 2, GLTD2_HUMAN.

Background: The GLTP (glycolipid transfer protein) superfamily is defined by a unique lipid transfer/binding fold (GLTP fold) that accelerate glycolipid intermembrane transfer. GLTPD2 is a 291 amino acid protein that belongs to the GLTP family. The gene encoding GLTPD2 maps to human chromosome 17, which comprises over 2.5 % of the human genome and encodes over 1,200 genes. Two key tumor suppressor genes are associated with chromosome 17, p53 and BRCA1. Malfunction or loss of p53 expression is associated with malignant cell growth and Li-Fraumeni syndrome. Neurofibromatosis, a condition characterized by neural and epidermal lesions, and dysregulated Schwann cell growth are both linked to mutations on chromosome 17. Alexander disease, Birt-Hogg-Dube syndrome and Canavan disease are also associated with chromosome 17.